Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells

Cell Regulation
L A PukacM J Karnovsky

Abstract

Heparin is a potent inhibitor of vascular smooth muscle cell (VSMC) growth. In this paper we show that heparin suppressed the induction of c-fos and c-myc mRNA in rat and calf VSMC. This effect of heparin is closely associated with its growth-inhibitory activity, as shown by isolating and characterizing a strain of rat VSMC that was resistant to heparin's antiproliferative effect; heparin did not suppress c-fos mRNA induction in these cells. Moreover, neither a nonantiproliferative heparin fragment or other glycosaminoglycans that lack growth-inhibitory activity repressed c-fos or c-myc mRNA levels. The effect of heparin on c-fos mRNA induction was selective for specific mitogens, as heparin inhibited c-fos mRNA induction in phorbol 12-myristate 13-acetate (TPA) stimulated but not epidermal growth factor (EGF) stimulated VSMC. The effect of heparin on gene expression is independent of ongoing protein synthesis, and inhibition of c-fos mRNA is at the transcriptional level. These results suggest that heparin may selectively inhibit a protein kinase C-dependent pathway for protooncogene induction and that this may be one mechanism used by heparin to inhibit cell proliferation.

References

Oct 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·W J PledgerC D Scher
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M EinatA Kimchi
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W RanJ Campisi
Sep 1, 1988·The Journal of Cell Biology·R A MajackP J Gebicke-Haerter
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T C WrightJ Campisi
Dec 1, 1989·Journal of Cellular Physiology·J A PietenpolE B Leof
Jul 6, 1989·Nature·M SubramaniamM J Getz
Jul 18, 1986·Science·Y Nishizuka
Apr 1, 1985·The Journal of Cell Biology·L M FritzeR D Rosenberg
Feb 20, 1986·The New England Journal of Medicine·R Ross
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J T HoltA W Nienhuis
Oct 1, 1986·Journal of Cellular Physiology·C F ReillyR D Rosenberg
Feb 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·E KnightG J Jonak
Dec 1, 1985·Journal of Cellular Physiology·T C WrightM J Karnovsky
Jul 1, 1985·Journal of Cellular Physiology·J J CastellotM J Karnovsky
May 1, 1984·Analytical Biochemistry·J Meinkoth, G Wahl
Aug 1, 1981·The Journal of Cell Biology·J J CastellotM J Karnovsky

❮ Previous
Next ❯

Citations

Jan 1, 1992·Journal of Cellular Physiology·J D San AntonioM J Karnovsky
May 1, 1991·Journal of the American College of Cardiology·B C BerkR W Alexander
Jan 22, 2010·Tissue Engineering. Part a·Somali ChaterjiAlyssa Panitch
Dec 22, 1998·Glycobiology·J Malmström, G Westergren-Thorsson
Jun 19, 2010·Journal of Biomaterials Science. Polymer Edition·Yan SuXiumei Mo
Jul 1, 1992·The Journal of Clinical Investigation·S Kartha, F G Toback
Aug 31, 2000·Biochemical and Biophysical Research Communications·W H Fan, M J Karnovsky
Feb 26, 2005·The Journal of Biological Chemistry·Stephen FascianoChandrashekhar V Patel
May 21, 1998·Critical Reviews in Clinical Laboratory Sciences·G Gambaro, B Baggio
Jun 27, 1998·Connective Tissue Research·J D San AntonioL A Pukac
May 23, 2003·Journal of Vascular and Interventional Radiology : JVIR·Peter H LinStephen R Hanson
Jun 27, 2006·Experimental and Molecular Pathology·Feng GuoWilliam D Wagner
Nov 25, 2005·Biomaterials·Emma Luong-VanSimon M Cool
Nov 23, 2006·The International Journal of Biochemistry & Cell Biology·Carla F FelixHelena M Scofano
Mar 24, 2005·Journal of Vascular Research·Kazue Kuwahara-WatanabeMasatoshi Kawana
Sep 14, 2004·Current Opinion in Lipidology·Ulf HedinPhan-Kiet Tran
Jan 18, 2007·Journal of Cellular Physiology·Yuan-Tao LiuDouglas M Templeton
Oct 7, 2004·Cell Motility and the Cytoskeleton·Nathalie F WorthBarbara E Rolfe
Feb 1, 1995·Circulation Research·E R EdelmanR D Rosenberg
May 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J D San AntonioL A Pukac
Oct 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·C RogersE R Edelman
Sep 17, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Rekha C PatelChandrashekhar V Patel
Dec 16, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·F G WeltC Rogers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.